Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

Name: Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial
License: Public Domain

Fudan University · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

rectal-cancer

rectal cancer, moderately hypofractionated radiotherapy, serplulimab, pmmr/mss

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 123441 · SHA-256 e5bfa50054351e7a
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.